Clinical Trials Browser

Phase 2/3 × Recruiting × Idarubicin × Clear all

NCT02416388 2024-08-07

BIG-1

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05313958 2023-07-27

SCCLG-M5

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Monocytic, Acute